ECL.NYSEEcolab INC

Form 4: Ecolab Director John J. Zillmer Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Director John J. Zillmer reports the acquisition of stock options in Ecolab Inc.

Summary

  • On May 6, 2024, John J. Zillmer, a director of Ecolab Inc., reported a transaction involving derivative securities.
  • Zillmer acquired 934 non-employee director stock options with an exercise price of $228.255.
  • The options become exercisable in installments over a year, starting August 6, 2024, and expire on May 6, 2034.
  • Zillmer directly owns 45,131.84 shares of Ecolab common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock option grant) for a company director, suggesting a neutral to slightly positive sentiment as it aligns director interests with shareholders.

Positives

  • The acquisition of stock options by a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.

Future Outlook

The options vest over time, incentivizing the director to contribute to the company's long-term success.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.

Comparison to Industry Standards

  • Stock options are a standard component of compensation packages for directors in companies of Ecolab's size and industry.
  • The vesting schedule and exercise price are typical for such grants.

Stakeholder Impact

  • The stock option grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates

DateDescription
05/06/2024Date of transaction: John J. Zillmer acquired stock options.
05/06/2024Date of grant: Non-Employee Director Stock Option (Right to Buy).
08/06/2024First vesting date: 25% of the option shares become exercisable.
05/06/2034Expiration date of the stock options.
05/08/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.